Great expectations and challenges of artificial intelligence in the screening of diabetic retinopathy

Mingwei Zhao^{1

2

3}, Yuzhen Jiang^{4

5}

Affiliations

¹ Department of Ophthalmology, People's Hospital, Peking University, 11 South Avenue Xi Zhi Men, Beijing, 100044, China. dr_zhaomingwei@163.com.
² Eye diseases and optometry institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, 11 South Avenue Xi Zhi Men, Beijing, 100044, China. dr_zhaomingwei@163.com.
³ College of Optometry, Peking University Health Science Center, Peking University, 11 South Avenue Xi Zhi Men, Beijing, 100044, China. dr_zhaomingwei@163.com.
⁴ Moorfields Eye Hospital, 162 City Rd, London, EC1V 2PD, UK.
⁵ UCL Institute of Ophthalmology, 43 Bath Street, London, EC1V 9EL, UK.

Editorial

Mingwei Zhao et al. Eye (Lond). 2020 Mar.

. 2020 Mar;34(3):418-419.

doi: 10.1038/s41433-019-0629-2. Epub 2019 Dec 11.

Mingwei Zhao^{1

2

3}, Yuzhen Jiang^{4

5}

¹ Department of Ophthalmology, People's Hospital, Peking University, 11 South Avenue Xi Zhi Men, Beijing, 100044, China. dr_zhaomingwei@163.com.
² Eye diseases and optometry institute, Beijing Key Laboratory of Diagnosis and Therapy of Retinal and Choroid Diseases, 11 South Avenue Xi Zhi Men, Beijing, 100044, China. dr_zhaomingwei@163.com.
³ College of Optometry, Peking University Health Science Center, Peking University, 11 South Avenue Xi Zhi Men, Beijing, 100044, China. dr_zhaomingwei@163.com.
⁴ Moorfields Eye Hospital, 162 City Rd, London, EC1V 2PD, UK.
⁵ UCL Institute of Ophthalmology, 43 Bath Street, London, EC1V 9EL, UK.

No abstract available

Conflict of interest statement

The authors declare that they have no conflict of interest.

Artificial intelligence in diabetic retinopathy.
Williamson TH. Williamson TH. Eye (Lond). 2021 Feb;35(2):684. doi: 10.1038/s41433-020-0855-7. Epub 2020 Apr 14. Eye (Lond). 2021. PMID: 32291403 Free PMC article. No abstract available.

1. King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31. doi: 10.2337/diacare.21.9.1414. - DOI - PubMed
1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53. doi: 10.2337/diacare.27.5.1047. - DOI - PubMed
1. Song P, Yu J, Chan KY, Theodoratou E, Rudan I. Prevalence, risk factors and burden of diabetic retinopathy in China: a systematic review and meta-analysis. J Glob Health. 2018;8:010803. doi: 10.7189/jogh.08.010803. - DOI - PMC - PubMed
1. Gadkari SS, Maskati QB, Nayak BK. Prevalence of diabetic retinopathy in India: The All India Ophthalmological Society Diabetic Retinopathy Eye Screening Study 2014. Indian J Ophthalmol. 2016;64:38–44. doi: 10.4103/0301-4738.178144. - DOI - PMC - PubMed
1. Jones CD, Greenwood RH, Misra A, Bachmann MO. Incidence and progression of diabetic retinopathy during 17 years of a population-based screening program in England. Diabetes Care. 2012;35:592–6. doi: 10.2337/dc11-0943. - DOI - PMC - PubMed